Dr. Roger Sawhney has served as a director of Actuate Therapeutics since August 2024. He currently serves as Chief Business Officer of both Regor Pharmaceuticals and Neuvogen, and was previously Chief Financial Officer of LB Pharmaceuticals, Inc. (2024-2025) and of Garuda Therapeutics, Inc. (2022-2023). He earlier served as Chief Business Officer and then Chief Financial Officer of Omega Therapeutics, Inc., as Director of the healthcare investment platform at KKR & Co., as Senior Vice President and Head of Global Corporate Strategy at Novartis AG, and as a Partner at Bain & Company and Managing Director at the Boston Consulting Group. He serves as a director of Arbutus Biopharma and Adlai Nortye Ltd., among other companies. Dr. Sawhney earned an M.D. from Harvard Medical School and a B.A. in Economics from Stanford University.